In addition, the inhibition of adiponectin may be mediated in part by the P44/42 MAP kinase (Fasshauer et al., 2003), which may result in lower adiponectin levels in RA patients than in healthy individuals. Here, ADIPOQ is linked to rheumatoid arthritis.